Swiss Drugmaker Complains Of Chinese Antibiotics Dumping

(MENAFN- Swissinfo) Swiss pharma firm Sandoz is stepping up its criticism of imports of low-priced antibiotics from China. Select your language

Generated with artificial intelligence. Listening: Swiss drugmaker complains of Chinese antibiotics dumping This content was published on May 28, 2026 - 15:44 3 minutes Keystone-SDA

Français fr Sandoz à l'offensive contre les antibiotiques chinois bradés Original Read more: Sandoz à l'offensive contre les antibiotiques chinois br

+Get the most important news from Switzerland in your inbox

The Swiss generics giant has submitted a draft complaint to the European Commission.

The group is targeting imports of penicillin – the active ingredient in amoxicillin – from China. According to the company, Chinese suppliers are heavily subsidised and can therefore offer antibiotics at very low prices, distorting competition.

More More New treatments Swiss inaction threatens global antibiotic development push

This content was published on Jul 8, 2025 Switzerland risks stalling global antibiotic innovation amid rising resistance.

Read more: Swiss inaction threatens global antibiotic development

“Up to 90% of the world's antibiotic active substances are now produced outside Europe, mainly in China. This situation constitutes a critical strategic vulnerability, with direct consequences for public health, crisis preparedness and Europe's ability to defend its status in a rapidly changing world,” stated CEO Richard Saynor.

Sandoz is particularly critical of the role of Chinese suppliers, who influence the market with heavily subsidised and therefore cheap antibiotics.“I don't think that politicians are unaware of this,” explained the CEO in an interview with AWP. He believes that European decision-makers have been“too hesitant for too long”.

More More Research frontiers Your questions answered: Are there alternatives to antibiotics?

This content was published on Nov 20, 2025 Readers asked us a host of questions about rising resistance to antibiotics. We have some answers.

Read more: Your questions answered: Are there alternatives to antibio

Saynor criticized policymakers for reacting too slowly. In his view, antibiotics are often valued only for their low price rather than their essential role in healthcare. For Richard Saynor, this is the fundamental problem.“Antibiotics are systematically undervalued, even though they play a central role in healthcare.”

Sandoz says it is fighting to keep Europe's last remaining antibiotics plant in operation, the Kundl site in Austria, which celebrates its 80th anniversary on Thursday.

Saynor acknowledges, however, that the European Union has made progress in the area of antibiotic supply under the“Alpbach Communiqué”, adopted at the end of a forum held in the Austrian town of Alpbach.

This memorandum stipulates that at least 30% of European countries' supplies should come from suppliers on the continent.

The draft European law on essential medicines (Critical Medicines Act) is also a step in the right direction, but the details of its implementation remain unclear, says the Sandoz CEO.

The multinational is calling on Europe to follow the example of India, which already imposes minimum import prices to protect its own antibiotic production.

More More Health systems Switzerland to strengthen measures against antibiotic resistance

This content was published on Nov 3, 2025 The federal government intends to strengthen measures against antibiotic resistance and support hospitals in setting up appropriate programmes.

Read more: Switzerland to strengthen measures against antibiotic resis

Adapted from French by AI/mga

MENAFN28052026000210011054ID1111180311